Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 15 12 2018
medline: 19 11 2019
entrez: 15 12 2018
Statut: ppublish

Résumé

The chondroitin sulfate proteoglycan 4 ( CSPG4) gene encodes a transmembrane proteoglycan (PG) constituting the largest and most structurally complex macromolecule of the human surfaceome. Its transcript shows an extensive evolutionary conservation and, due to the elaborated intracellular processing of the translated protein, it generates an array of glycoforms with the potential to exert variant-specific functions. CSPG4-mediated molecular events are articulated through the interaction with more than 40 putative ligands and the concurrent involvement of the ectodomain and cytoplasmic tail. Alternating inside-out and outside-in signal transductions may thereby be elicited through a tight functional connection of the PG with the cytoskeleton and its regulators. The potential of CSPG4 to influence both types of signaling mechanisms is also asserted by its lateral mobility along the plasma membrane and its intersection with microdomain-restricted internalization and endocytic trafficking. Owing to the multitude of molecular interplays that CSPG4 may engage, and thanks to a differential phosphorylation of its intracellular domain accounted by crosstalking signaling pathways, the PG stands out for its unique capability to affect numerous cellular phenomena, including those purporting pathologic conditions. We discuss here the progresses made in advancing our understanding about the structural-functional bases for the ability of CSPG4 to widely impact on cell behavior, such as to highlight how its multivalency may be exploited to interfere with disease progression.-Tamburini, E., Dallatomasina, A., Quartararo, J., Cortelazzi, B., Mangieri, D., Lazzaretti, M., Perris, R. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.

Identifiants

pubmed: 30550356
doi: 10.1096/fj.201801670R
doi:

Substances chimiques

Antigens 0
CSPG4 protein, human 0
Chondroitin Sulfate Proteoglycans 0
Membrane Proteins 0
Proteoglycans 0
chondroitin sulfate proteoglycan 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3112-3128

Auteurs

Elisa Tamburini (E)

Centre for Molecular and Translational Oncology (COMT), University of Parma, Parma, Italy.

Alice Dallatomasina (A)

Division of Experimental Oncology, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy; and.

Jade Quartararo (J)

Centre for Molecular and Translational Oncology (COMT), University of Parma, Parma, Italy.

Barbara Cortelazzi (B)

Centre for Molecular and Translational Oncology (COMT), University of Parma, Parma, Italy.

Domenica Mangieri (D)

Department of Medical Sciences, University of Foggia, Foggia, Italy.

Mirca Lazzaretti (M)

Centre for Molecular and Translational Oncology (COMT), University of Parma, Parma, Italy.

Roberto Perris (R)

Centre for Molecular and Translational Oncology (COMT), University of Parma, Parma, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH